| PFE | 7.51% | 24.58 | -0.12% | 42,957 | |
| JNJ | 7.39% | 162.98 | -1.09% | 6,880 | |
| ABBV | 7.15% | 191.40 | +0.43% | 5,431 | |
| MRK | 7.00% | 81.52 | -1.10% | 12,307 | |
| BMY | 6.26% | 48.06 | +1.89% | 19,043 | |
| VTRS | 3.97% | 9.27 | +2.09% | 61,503 | |
| GILD | 3.82% | 108.80 | -0.96% | 4,966 | |
| AMGN | 3.78% | 298.25 | -0.26% | 1,843 | |
| ZTS | 3.73% | 150.03 | -1.00% | 3,394 | |
| BIIB | 3.71% | 128.69 | +0.18% | 4,040 |
First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF is an exchange traded fund launched and managed by First Trust Advisors LP. The fund invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences, pharmaceuticals sectors. The fund invests in value, growth and volatile stocks of companies across diversified market capitalization. It seeks to track the performance of the Nasdaq US Smart Pharmaceuticals Index, by using full replication technique. First Trust Exchange-Traded Fund VI - First Trust Nasdaq Pharmaceuticals ETF was formed on September 20, 2016 and is domiciled in the United States.